The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China

被引：0
|
作者：
Shuyan Gu
Jinghong Gu
Xiaoyong Wang
Xiaoling Wang
Lu Li
Hai Gu
Biao Xu
机构：
[1] Nanjing University,Center for Health Policy and Management Studies, School of Government
[2] University of Washington,Department of Economics
[3] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Health Insurance Office
[4] Shanghai Jiao Tong University School of Medicine,Department of Endocrinology, Xinhua Hospital
[5] First Affiliated Hospital of Dalian Medical University,Department of Pharmacy
来源：
Health Economics Review | / 14卷
关键词：
Cost-effectiveness; Semaglutide; Sitagliptin; Type 2 diabetes; China;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China
    Gu, Shuyan
    Gu, Jinghong
    Wang, Xiaoyong
    Wang, Xiaoling
    Li, Lu
    Gu, Hai
    Xu, Biao
    HEALTH ECONOMICS REVIEW, 2024, 14 (01)
  • [2] Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting
    Martin, Virginia
    Vidal, Josep
    Malkin, Samuel J. P.
    Hallen, Nino
    Hunt, Barnaby
    ADVANCES IN THERAPY, 2020, 37 (10) : 4427 - 4445
  • [3] Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting
    Virginia Martín
    Josep Vidal
    Samuel J. P. Malkin
    Nino Hallén
    Barnaby Hunt
    Advances in Therapy, 2020, 37 : 4427 - 4445
  • [4] Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK
    Viljoen, Adie
    Hoxer, Christina S.
    Johansen, Pierre
    Malkin, Samuel
    Hunt, Barnaby
    Bain, Stephen C.
    DIABETES OBESITY & METABOLISM, 2019, 21 (03): : 611 - 621
  • [5] Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China
    Lei Liu
    Zhen Ruan
    Carolina Oi Lam Ung
    Yawen Zhang
    Yang Shen
    Sheng Han
    Ruxu Jia
    Jingtao Qiao
    Hao Hu
    Lixin Guo
    Diabetes Therapy, 2023, 14 : 93 - 107
  • [6] Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China
    Liu, Lei
    Ruan, Zhen
    Ung, Carolina Oi Lam
    Zhang, Yawen
    Shen, Yang
    Han, Sheng
    Jia, Ruxu
    Qiao, Jingtao
    Hu, Hao
    Guo, Lixin
    DIABETES THERAPY, 2023, 14 (01) : 93 - 107
  • [7] Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
    Malkin, Samuel J. P.
    Russel-Szymczyk, Monika
    Liidemann, Girtel
    Volke, Vallo
    Hunt, Barnaby
    DIABETES THERAPY, 2019, 10 (01) : 159 - 176
  • [8] Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
    Johansen, Pierre
    Chubb, Barrie
    Hunt, Barnaby
    Malkin, Samuel J. P.
    Sandberg, Anna
    Capehorn, Matthew
    ADVANCES IN THERAPY, 2020, 37 (05) : 2427 - 2441
  • [9] The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia
    Malkin, Samuel J. P.
    Russel-Szymczyk, Monika
    Psota, Marek
    Hlavinkova, Lucia
    Hunt, Barnaby
    ADVANCES IN THERAPY, 2019, 36 (08) : 2034 - 2051
  • [10] Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
    Pierre Johansen
    Barrie Chubb
    Barnaby Hunt
    Samuel J. P. Malkin
    Anna Sandberg
    Matthew Capehorn
    Advances in Therapy, 2020, 37 : 2427 - 2441
12345